Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Uremic toxicity: urea and beyond.

T A Depner1

  • 1Nephrology Division, Department of Medicine, University of California-Davis, 4150 V. St., Sacramento, CA 95817, USA. tadepner@ucdavis.edu

Seminars in Dialysis
|August 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute renal failure: a two-year single center report.

The International journal of artificial organs·2004
Same author

Daily dialysis in the intensive care unit.

The International journal of artificial organs·2002
Same author

Catheter performance.

Seminars in dialysis·2002
Same author

Urea kinetics with central vein access and unused AV access.

Seminars in dialysis·2001
Same author

Daily hemodialysis efficiency: an analysis of solute kinetics.

Advances in renal replacement therapy·2001
Same author

Is Kt/V urea a satisfactory measure for dosing the newer dialysis regimens?

Seminars in dialysis·2001
Same journal

Intracardiac Vascular Access for Hemodialysis Despite Associated Ascending Aortic Aneurysm.

Seminars in dialysis·2026
Same journal

Measures of Equivalent Hemodialysis Urea Clearance and Their Proposed Utility for Monitoring Adequacy.

Seminars in dialysis·2026
Same journal

Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis.

Seminars in dialysis·2026
Same journal

Severe Hematoma Following Initial Arteriovenous Fistula Puncture in a Hemodialysis Patient, Emphasizing Thoracic Outlet Syndrome: A Case Report.

Seminars in dialysis·2026
Same journal

Phosphate Kinetic Modeling in Patients Treated With Hemodialysis or Hemodiafiltration: A Prospective, Multicenter, Cross-Sectional Study.

Seminars in dialysis·2026
Same journal

Impact of Expanded Hemodialysis on Inflammation and Iron Metabolism in Chronic Hemodialysis Patients.

Seminars in dialysis·2026
See all related articles

Urea clearance is a flawed measure of dialysis adequacy because uremic toxicity likely stems from multiple solutes. Further research into other solute kinetics is needed for optimized dialysis treatments.

Area of Science:

  • Nephrology
  • Uremic Toxin Research

Background:

  • Uremia is a toxic state caused by accumulated solutes in body fluids.
  • Dialyzer clearance of urea is the standard measure for dialysis adequacy.
  • Current measures may be compromised by a lack of knowledge regarding other toxic solutes.

Purpose of the Study:

  • To evaluate the effectiveness of urea as a surrogate toxin for measuring dialysis adequacy.
  • To explore the potential role of other accumulated solutes in uremic toxicity.
  • To identify better markers for optimizing dialysis treatments.

Main Methods:

  • Review of current understanding of uremic toxicity and dialysis.
  • Analysis of urea's properties as a surrogate toxin compared to other solutes.
  • Discussion of the need for further kinetic studies on various uremic solutes.

Related Experiment Videos

Main Results:

  • Urea's high diffusibility, while making it easy to measure, may limit its effectiveness as a surrogate for uremic toxicity, especially with frequent dialysis.
  • Uremic toxicity might be a summation effect of multiple subtoxic solutes.
  • Other solutes may correlate better with uremic symptoms than urea.

Conclusions:

  • Urea clearance may not be the optimal measure of dialysis adequacy.
  • Further research into the kinetics, generation rates, and distribution volumes of other solutes is crucial.
  • Optimizing dialysis may require monitoring a broader range of solutes to better understand uremia pathogenesis.